Company research / CRBU
Caribou Biosciences, Inc. (CRBU)
- Sector Manufacturing
- Incorporated DE
- Fiscal year ends Dec 31
For the year ended 2025-12-31, Caribou Biosciences, Inc. reported revenue of $11.16M. Revenue grew 11.7% from the prior annual period. Over the twelve months to 2026-06-30, revenue was $10.04M.
Key ratios (year ended 2025-12-31)
n/m
Operating margin
n/m
Net margin
-121.2%
Return on year-end equity
11.7%
Revenue growth (YoY)
Beyond the statements
Follow the company.
Explore new filings, reported insider transactions and company relationships.